Interventional endoscopy procedures use flexible camera-equipped endoscopes—sometimes integrated with ultrasound—to diagnose and treat complex disorders of the digestive tract using minimally invasive, surgery-sparing techniques. Under the leadership of Dr. Christopher Hamerski of KP San Francisco and Dr. Gene Ma of…
Interventional endoscopy procedures use flexible camera-equipped endoscopes—sometimes integrated with ultrasound—to diagnose and treat complex disorders of the digestive tract using minimally invasive, surgery-sparing techniques. Under the leadership of Dr. Gene Ma of KP Greater San Jose Area and Dr. Christopher…
Fernando Velayos, MD, joined TPMG in 2017 as chair of the first KP Northern California Regional Inflammatory Bowel Disease (IBD) Program, with a mandate to overhaul care for about 35,000 IBD patients across the region. Ulcerative colitis and Crohn’s disease—collectively…
When wildfires licked the edges of KP Santa Rosa in 2017 and forced the medical center’s gastrointestinal (GI) unit to close for over a month, Chief of Gastroenterology Jeff Fox, MD, mobilized a team of volunteer physicians and staff from…
Dr. Li’s passion for supporting patients with Lynch syndrome (LS) spans an entire career. Patients who have LS, a hereditary condition that greatly increases the risk of colorectal cancer (CRC) and other cancers, carry a lifetime risk of up to…
Colorectal cancer is the second leading cause of cancer death in this country. Yet convincing patients to get screened can be one of the biggest challenges primary care physicians and gastroenterologists face. To remedy this and improve patient health, Dr…
Colorectal cancer is the second leading cause of cancer death in this country. Yet convincing patients to get screened can be one of the biggest challenges primary care physicians and gastroenterologists face. To remedy this and improve patient health, Dr…
Colorectal cancer is the third most common cancer and the second leading cause of cancer deaths among adults in the United States. Yet when caught early through regular screening, the 5-year relative survival rate is approximately 90%. Thanks to the…
Though nearly 70 million people in the United States have been vaccinated against hepatitis B (HBV), approximately 850,000 already are infected. HBV can become a chronic infection, putting people at high risk of death from cirrhosis and liver cancer. But…
Dr. Guardino has transformed his department and influenced regional practice. There is no question that his model of care is saving lives. — Richard Isaacs, MD, Physician-in-Chief
“The main driver behind this study is to find out if we can do better at detecting colon cancer. We learned that yes, even when you’re meeting quality standards, it’s possible to do better.”
"Dr. Szpakowski’s study provides invaluable evidence for all clinicians caring for patients with HBV."
Dr. Cornish’s legacy is one of passionate, innovative, results driven leadership. He exemplifies TPMG excellence at its best.
“I want my research to make a difference in people’s lives,” says Dr. Michael Lawson. His research has been making a difference for decades now, especially for people with serious gastrointestinal problems that affect their health, well-being and quality of…
Dr. Rouillard puts her leadership skills to excellent use in her department and the organization.
"One of the most rewarding aspects of our model of care is empowering patients so they can be active participants in the management of their disease."
